Icon of the Instituts for Quality and Efficiency in Health Care

Addendum

Decision aid for biomarker tests in breast cancer - Addendum to Commission D14-01

Status
Status: Commission completed
Project no.
P17-03
Last updated

Report documents

  1. Addendum

    Decision aid for biomarker tests in breast cancer - Addendum to Commission D14-01

    published on
    Document type
    PDF document, 1 MB, DE, not accessible
    Download file : Addendum (PDF document, 1 MB, DE, not accessible)

Additional information

IQWiG health information

After surgery for early-stage breast cancer, chemotherapy can reduce the risk of the cancer returning. But sometimes the disadvantages may outweigh the advantages.

Early-stage breast cancer: Does it make sense to have chemotherapy?

Project details

Project no.
P17-03
Commission
Commission awarded on 18.05.2017 by the Federal Joint Committee (GBA).
Report type
Addendum
Status
Commission completed
Department/Division
Health Information
Topic
Cancer
Note

The decision aid developed in this project was updated in 2019. The current version can be found at Früher Brustkrebs: Wann ist ein Biomarker-Test sinnvoll? (German version) and Früher Brustkrebs: Ist eine Chemotherapie sinnvoll? (German version)

Connected Projects

  1. Report

    Biomarker-based tests for the decision for or against adjuvant systemic chemotherapy in primary breast cancer

    Project no.
    D14-01
    Last updated

    Status: Commission completed

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page